does state insurance cover glp 1 CMS Issues Coverage Guidance on GLP-1 Anti-Obesity Drugs McKee's proposed FY2027 budget drops

Scientifically Backed for Real Results: Clinical studies show that 10g (the amount in 4 tsp) helps promote satiety within 30 minutes after a meal and helps maintain appetite control for up to 4 hours.* Designed for convenient daily use

Effectiveness and Impact Significant Weight Loss: Phase 2 studies showed up to roughly 20% average body weight loss at 52 weeks in participants with obesity

GLP-1s are moving to pills for a lower cost A new weight-loss pill is entering the market at a lower out-of-pocket cost, removing one of the biggest barriers to GLP-1 adoption and opening the door to much broader use

95% CI 0.310.50), MACEs (aHR 0.66

Easy, convenient nutrition that fits into any routine

In the ACHIEVE-1 phase 3 trial, the oral small-molecule GLP-1 receptor agonist orforglipron significantly reduced the glycated hemoglobin level over a period of 40 weeks in adults with early type 2 diabetes